Mucolab: Vertex and the French Cystic Fibrosis Society choose Ad Scientiam

The Ad Scientiam team is proud to announce this new partnership with the French Cystic Fibrosis Society (Société Française de la Mucoviscidose) and Vertex Pharmaceuticals.

This ambitious innovation project aims to improve the home monitoring of patients with cystic fibrosis, thanks to new respiratory digital biomarkers.

This collaboration strengthens Ad Scientiam's commitment to creating new assessment standards, serving patients and healthcare professionals.